RecruitingNCT04919265

Mother-Infant Cohort Study in Malaysia and China

Breastmilk, Infant Gut Microbiome and the Impact on Infant Health: a Prospective Mother-Infant Cohort Study in Malaysia and China


Sponsor

Universiti Putra Malaysia

Enrollment

200 participants

Start Date

Jun 3, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This mother-infant cohort study aims to determine the geographic differences in the microbial profiles in breast milk from mothers living in Malaysia and China that are potentially important determinants of infant development. It also aims to determine the impact of gut microbiome on infant health (temperament, gastrointestinal symptoms, eczema symptoms, and asthma symptoms).


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Inclusion Criteria4

  • Pregnant women aged between 18 and 45 years old
  • Pregnant women who attend the antenatal check-up at the selected clinics/hospitals
  • Pregnant women with the gestational age of less than 12 weeks
  • Pregnant women who plan to attend post-natal check-ups for at least one year at the same clinic/hospital

Exclusion Criteria4

  • Pregnant women who are diagnosed with immune deficiency
  • Pregnant women who have a multiple pregnancy and preterm delivery (\<37 weeks)
  • Pregnant women who plan to move out of the study area in the next one year
  • Pregnant women with fetal/newborn with congenital abnormalities

Interventions

OTHERNo intervention - mother-infant cohort study

There are no interventions because it is a mother-infant cohort study


Locations(1)

Private hospital

Kajang, Selangor, Malaysia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04919265


Related Trials